Physician profile
Chris James Cottrell
NPI 1215989827
$9,744.33
in general payments reported to CMS, 2019-2025
15 companies · $15.57 in 2025
The $15.57 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $104 · 2021: $6,545 · 2022: $451 · 2023: $193 · 2024: $2,049 · 2025: $15.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Food and Beverage | $257.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,545.49 | 2019-2024 | |
| Davol INC. | $363.64 | 2019-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $255.54 | 2019-2022 | |
| Abbvie INC. | $141.41 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Medtronic, INC. | $105.20 | 2021-2023 | Signia |
| Boston Scientific Corporation | $90.79 | 2022 | |
| W. L. Gore & Associates, INC. | $49.29 | 2021-2022 | |
| Conmed Corporation | $41.67 | 2019 | |
| Smith+Nephew, INC. | $40.87 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $29.48 | 2023 | Exparel |
| Becton, Dickinson and Company | $20.58 | 2021 | |
| Baudax Bio INC. | $18.36 | 2021 | |
| Covidien LP | $14.98 | 2019 | |
| Tela Bio, INC. | $14.20 | 2020 | |
| Teleflex LLC | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Cottrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.